Zonisamide Tablet Franchise in Ahmedabad

Epilepsy Treatment Tablet Supplier in Mumbai

Neurology Medicine Distributor in Delhi

Antiepileptic Pharma Franchise in Bangalore

Zonisamide Tablet Stockist in Hyderabad
Neurology Medicine Manufacturer & Exporter in Chandigarh

Home/Products /zonisamide-25mg-tablet

Zonimild 25 Tablet

Composition : Zonisamide (25mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Strip

Packaging : 10*10

Price : ₹0/-

Please Contact For Best Price

Zonimild 25 Tablet contains Zonisamide 25mg, an antiepileptic medicine used for the management of partial-onset seizures in patients with epilepsy. This lower-strength formulation is often prescribed during dose initiation or titration under medical supervision.

Zonisamide helps control seizures by modulating sodium and calcium ion channels in the brain, thereby reducing excessive neuronal firing and stabilizing electrical activity in the central nervous system.

The 25mg strength allows clinicians to customize treatment regimens, especially for patients who require gradual dose escalation to achieve optimal seizure control while maintaining tolerability.

Zonimild 25 Tablet is valued for its consistent therapeutic performance, neurological safety profile, and suitability for long-term epilepsy management, making it a reliable option in neurology-based treatment plans.

Read More

About the Product

Zonimild 25 Tablet contains Zonisamide 25mg, an antiepileptic medicine used for the management of partial-onset seizures in patients with epilepsy. This lower-strength formulation is often prescribed during dose initiation or titration under medical supervision.

Zonisamide helps control seizures by modulating sodium and calcium ion channels in the brain, thereby reducing excessive neuronal firing and stabilizing electrical activity in the central nervous system.

The 25mg strength allows clinicians to customize treatment regimens, especially for patients who require gradual dose escalation to achieve optimal seizure control while maintaining tolerability.

Zonimild 25 Tablet is valued for its consistent therapeutic performance, neurological safety profile, and suitability for long-term epilepsy management, making it a reliable option in neurology-based treatment plans.

Common side effects may include dizziness, drowsiness, headache, nausea, reduced appetite, and fatigue. Some patients may experience weight loss or difficulty with concentration. Rare side effects include allergic reactions, kidney stones, or metabolic acidosis.

Zonimild 25 Tablet is indicated for the treatment of partial-onset seizures in adults, either as monotherapy or as adjunctive therapy. It is especially useful during dose initiation or titration phases in epilepsy management.

Zonimild 25 Tablet should be taken only as prescribed by a healthcare professional. Do not stop the medication abruptly, as it may increase seizure risk. Use with caution in patients with renal disorders or known sulfonamide hypersensitivity.

Store Zonimild 25 Tablet in a cool, dry place away from heat, light, and moisture. Keep out of reach of children and use before the expiry date.

Get in Touch

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our Successful network today.

Quick Navigation

1500+ Products

Our Divisions

All Therapeutics

Disclaimer: Pharma Insights are based on operational standards as of March 2026. All territories are subject to availability and Revised Schedule M compliance.